CONCORDBIO.NS Balance Sheet
Concord Biotech Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 3 years on file
(FY2023-24 to FY2025-26)
· fetched 2026-08-23 21:43
| Line item | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|
| Property, Plant and Equipment | ₹571.73 Cr. | ₹791.80 Cr. | ₹785.72 Cr. | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹211.48 Cr. | ₹50.13 Cr. | ₹78.16 Cr. | CapitalWorkInProgress |
| Goodwill | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.40 Cr. | Goodwill |
| Other Intangible Assets | ₹3.58 Cr. | ₹2.28 Cr. | ₹2.44 Cr. | OtherIntangibleAssets |
| Non-current Investments | ₹0.00 Cr. | ₹17.99 Cr. | ₹84.94 Cr. | NoncurrentInvestments |
| Other Non-current Assets | ₹7.98 Cr. | ₹20.56 Cr. | ₹15.92 Cr. | OtherNoncurrentAssets |
| Total Non-current Assets | ₹804.48 Cr. | ₹899.01 Cr. | ₹984.62 Cr. | NoncurrentAssets |
| Inventories | ₹207.95 Cr. | ₹239.67 Cr. | ₹326.36 Cr. | Inventories |
| Trade Receivables | ₹349.61 Cr. | ₹521.65 Cr. | ₹460.20 Cr. | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹15.14 Cr. | ₹0.90 Cr. | ₹12.19 Cr. | CashAndCashEquivalents |
| Current Investments | ₹243.70 Cr. | ₹316.54 Cr. | ₹402.06 Cr. | CurrentInvestments |
| Other Current Assets | ₹28.49 Cr. | N/A | ₹22.68 Cr. | OtherCurrentAssets |
| Total Current Assets | ₹896.23 Cr. | ₹1,135.24 Cr. | ₹1,250.11 Cr. | CurrentAssets |
| Total Assets | ₹1,700.71 Cr. | ₹2,034.25 Cr. | ₹2,234.73 Cr. | Assets |
| Equity Share Capital | ₹10.46 Cr. | ₹10.46 Cr. | ₹10.46 Cr. | EquityShareCapital |
| Other Equity | ₹1,516.18 Cr. | ₹1,802.26 Cr. | ₹2,006.60 Cr. | OtherEquity |
| Equity Attributable to Owners | ₹1,526.65 Cr. | ₹1,812.72 Cr. | ₹2,017.06 Cr. | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | N/A | ₹0.00 Cr. | ₹-1.92 Cr. | NonControllingInterest |
| Total Equity | ₹1,526.65 Cr. | ₹1,812.72 Cr. | ₹2,015.14 Cr. | Equity |
| Long-term Borrowings | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹31.91 Cr. | ₹37.47 Cr. | ₹50.51 Cr. | NoncurrentLiabilities |
| Short-term Borrowings | ₹6.23 Cr. | ₹0.38 Cr. | ₹0.00 Cr. | BorrowingsCurrent |
| Trade Payables | ₹94.44 Cr. | ₹113.04 Cr. | ₹101.91 Cr. | TradePayablesCurrent |
| Other Current Liabilities | ₹6.27 Cr. | ₹11.32 Cr. | ₹12.34 Cr. | OtherCurrentLiabilities |
| Total Current Liabilities | ₹142.16 Cr. | ₹184.06 Cr. | ₹169.08 Cr. | CurrentLiabilities |
| Total Equity and Liabilities | ₹1,700.71 Cr. | ₹2,034.25 Cr. | ₹2,234.73 Cr. | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from CONCORDBIO.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).